Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome

X
Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alogliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Registrational
  • Acronyms EXAMINE
  • Sponsors Takeda; Takeda Global Research and Development Center
  • Most Recent Events

    • 26 Dec 2022 Results (n=193) assessing External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome published in the Diabetes, Obesity and Metabolism
    • 01 Jul 2021 Results assessing the clinical correlates of increased red blood cell distribution width, its potential mechanistic association with multiple circulating biomarkers, and its prognostic value in patients, published in the Diabetes, Obesity and Metabolism
    • 01 Sep 2020 Results of a post hoc analysis analysis assessing the impact of timing of enrolment on subsequent CV outcomes, presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top